zoom_in Click to enlarge

Samuel Wells

▲ ▼

description Samuel Wells Overview

Samuel Wells is a modern American surgeon specializing in endocrine surgery and surgical oncology at Mass General. His research significantly advanced understanding of medullary thyroid carcinoma. He developed key protocols for calcitonin screening within multiple endocrine neoplasia type 2, benefiting patients and guiding treatment strategies. This work primarily serves endocrinologists, oncologists, and those managing these specific conditions.

help Samuel Wells FAQ

What did Samuel Wells contribute to the treatment of medullary thyroid carcinoma?

Samuel Wells significantly advanced the understanding and surgical management of medullary thyroid carcinoma, a rare form of thyroid cancer originating from parafollicular C cells. He developed key protocols for calcitonin screening that enabled earlier detection of this cancer in patients with inherited multiple endocrine neoplasia (MEN) syndromes.

Where has Samuel Wells practiced surgery?

Samuel Wells has been affiliated with Massachusetts General Hospital (Mass General), where he practiced endocrine surgery and surgical oncology as part of the Harvard Medical School system. Mass General is one of the leading surgical centers in the United States and has been a hub for endocrine surgery research and training.

Why is calcitonin screening important in Samuel Wells' research?

Calcitonin serves as a tumor marker for medullary thyroid carcinoma, and Samuel Wells' screening protocols helped identify patients carrying genetic mutations associated with MEN2 who were at high risk of developing the cancer. This enabled prophylactic thyroidectomy—removal of the thyroid gland before cancer could develop or spread—dramatically improving outcomes for affected families.

How did Samuel Wells' work influence endocrine surgery as a specialty?

Samuel Wells' research on hereditary endocrine tumors and calcitonin screening helped establish systematic protocols that became part of the standard of care for patients with MEN syndromes. His work at Mass General contributed to the recognition of endocrine surgery as a distinct subspecialty within general surgery, with specific expertise in thyroid, parathyroid, and adrenal disease management.